Showing results (181-190 of 251) with videos related to
Sort By:
Pageof 26
Blood|April 1, 1987
Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow TransplantationG Gahrton, S Tura, M Flesch, et al.Tissue Antigens|August 25, 2015
HLA-A-B-C-DRB1-DQB1 phased haplotypes in 124 Nigerian families indicate extreme HLA diversity and low linkage disequilibrium in Central-West AfricaM Testi, M Battarra, G Lucarelli, et al.Experimental Hematology|January 1, 1987
Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processorN R Jin, R Hill, G Segal, et al.Bone Marrow Transplantation|October 1, 1996
Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemiaR Huss, H J Deeg, T Gooley, et al.Leukemia Research|January 1, 1985
Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporineC Irle, H J Deeg, C D Buckner, et al.Scandinavian Journal of Haematology|January 1, 1982
Fetal liver transplantation in 2 patients with acute leukaemia after total body irradiationG Lucarelli, T Izzi, A Porcellini, et al.Blood|August 1, 1994
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemiaR Storb, R Etzioni, C Anasetti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapyC H Weaver, F R Appelbaum, F B Petersen, et al.Bone Marrow Transplantation|April 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.Haematologica|July 1, 1991
Molecular analysis of HLA class II antigens in bone marrow transplanted thalassemic patientsM Andreani, C Carcassi, S Nesci, et al.Pageof 26